PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-59.37%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-86.14%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-763.74%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-763.74%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-12450.00%
Negative net income growth while VTLE stands at 18.07%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-10160.00%
Negative EPS growth while VTLE is at 14.29%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-10160.00%
Negative diluted EPS growth while VTLE is at 20.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.27%
OCF growth under 50% of VTLE's 18.58%. Michael Burry might suspect questionable revenue recognition or rising costs.
67.00%
FCF growth above 1.5x VTLE's 22.08%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-48.13%
Negative 10Y revenue/share CAGR while VTLE stands at 5.14%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-85.70%
Negative 5Y CAGR while VTLE stands at 5.14%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-80.18%
Negative 3Y CAGR while VTLE stands at 5.14%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
73.40%
10Y OCF/share CAGR above 1.5x VTLE's 24.02%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-68.02%
Negative 5Y OCF/share CAGR while VTLE is at 24.02%. Joel Greenblatt would question the firm’s operational model or cost structure.
-67.08%
Negative 3Y OCF/share CAGR while VTLE stands at 24.02%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-716.99%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-212.50%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-732.46%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
0.18%
Below 50% of VTLE's 76.88%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-59.22%
Negative 5Y equity/share growth while VTLE is at 76.88%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-71.24%
Negative 3Y equity/share growth while VTLE is at 76.88%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
397.82%
Dividend/share CAGR of 397.82% while VTLE is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
7.00%
Dividend/share CAGR of 7.00% while VTLE is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-50.19%
Negative near-term dividend growth while VTLE invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
0.50%
Our AR growth while VTLE is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
-13.56%
Negative asset growth while VTLE invests at 17.65%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-19.31%
We have a declining book value while VTLE shows 4.16%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.20%
We’re deleveraging while VTLE stands at 34.52%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-6.86%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.